PHS

Estonia’s First Pumped-Hydro Energy Storage Project Zero Terrain partners with the Estonian government and receives a grant of €1,9M

Retrieved on: 
Thursday, April 4, 2024
Business, PHS, Climate, Memorandum of understanding, PCI, Memorandum, McKinsey & Company, Government, Renewable energy

Additionally, Zero Terrain receives a grant of €1.98M from the state’s applied research programme to support Zero Terrain project development in Estonia and technology export.

Key Points: 
  • Additionally, Zero Terrain receives a grant of €1.98M from the state’s applied research programme to support Zero Terrain project development in Estonia and technology export.
  • The Zero Terrain Paldiski 500MW underground long-duration energy storage plant is a significant advancement of the conventional PHS technology, making it possible to build anywhere, even on flat land.
  • Paldiski Pumped Hydro Energy Storage plant is an EU Project of Common Interest (PCI project).
  • Estonia´s first long-duration energy storage project, Zero Terrain Paldiski, obtained the main building permits in December 2022.

ATMA CENA Psychedelic Healthcare Solutions Opens Psychedelic-Assisted Therapy Clinic in Calgary and Provides Update of its Clinic Network

Retrieved on: 
Thursday, March 14, 2024
Organization, Kat, Growth, Surgeon, Entrepreneurship, Patient, AB, PHS, ATMA, CENA, Transcranial magnetic stimulation, Mental health, Tran, SAP, PAT, Psilocybin, Psychedelic drug, Ecosystem, Safety, MDMA, Physician, Special access program, Nursing

CALGARY, AB, March 14, 2024 /PRNewswire/ - ATMA CENA Psychedelic Healthcare Solutions (PHS) is a collaboration of ATMA Journey Centers Inc. ("ATMA"), Cena Life Inc ., and partners across Canada to advance and expand access to psychedelic-assisted therapy (PaT) through the establishment of a clinic network.

Key Points: 
  • CALGARY, AB, March 14, 2024 /PRNewswire/ - ATMA CENA Psychedelic Healthcare Solutions (PHS) is a collaboration of ATMA Journey Centers Inc. ("ATMA"), Cena Life Inc ., and partners across Canada to advance and expand access to psychedelic-assisted therapy (PaT) through the establishment of a clinic network.
  • ATMA CENA PHS is pleased to announce commencement of the Calgary Clinic operations and its new location in Edmonton.
  • ATMA CENA Psychedelic Therapy Edmonton – 5555 Calgary Trail NW, Edmonton, AB
    ATMA CENA Psychedelic Therapy Calgary – 742 – 42nd Ave SE, Calgary, AB
    ATMA CENA Psychedelic Therapy Toronto – Woodbridge, Vaughan
    Utilizing Alberta's Psychedelic Drug Treatment Service Standards and the College of Physicians and Surgeons of Alberta Accreditation Program as foundational principles, ATMA CENA clinics will aim to support the establishment of the necessary infrastructure that enables standardized care.
  • In the delivery of PaT across Canada, ATMA CENA PHS aims to support care that is safe, operationally consistent, efficient, effective, and regulation compliant.

Mental Health Commission of Canada leads development of new program to support employers with psychological health and safety audits

Retrieved on: 
Thursday, March 7, 2024
Mental health, Health, Languages of Ethiopia, Social Development Canada, Mental, Employment, Organization, OHS, PHS, DSM-IV codes, ESDC

OTTAWA, ON, March 7, 2024 /CNW/ - The Mental Health Commission of Canada (MHCC) will see the development of an innovative new program that will support Canadian employers who want to foster the psychological health and safety of their workers.

Key Points: 
  • OTTAWA, ON, March 7, 2024 /CNW/ - The Mental Health Commission of Canada (MHCC) will see the development of an innovative new program that will support Canadian employers who want to foster the psychological health and safety of their workers.
  • Employment and Social Development Canada (ESDC) is contributing approximately $820,000 over three years to support the creation of MHCC's Psychological Health and Safety Audit Program.
  • Opening Minds is working to support employers that want to implement effective strategies and programs to protect and promote the psychological health and safety (PHS) of workers.
  • Employers that are interested in participating in the audit program begin with attending on the MHCC training course on Integrating Psychological Health and Safety.

Olympus Distribution of EndoClot® Showing Steady Adoption in the U.S.

Retrieved on: 
Friday, March 1, 2024
Static pressure, Traction, Blood, Physician, Tropical ulcer, Dissection, SIS, Polyp, Starch, Hemostasis, Artifact, Internationalized domain name, AMP, Inflammation, Adenoma, Safety, ESD, GI, Water, Classification, Perforated ulcer, CO2, PHS, Patient, Bleeding, Trauma, Perforation, Medical imaging

EndoClot products are used by more than 700 accounts, including most of the country's top-ranked (by size) Integrated Delivery Networks (IDNs).

Key Points: 
  • EndoClot products are used by more than 700 accounts, including most of the country's top-ranked (by size) Integrated Delivery Networks (IDNs).
  • Since their launch, EndoClot products have been discussed in close to 20 relevant professional education courses offered via Olympus Continuum, providing physicians with peer-demonstrations of EndoClot technology capabilities during procedures.
  • "Olympus knew that EndoClot technology would be important to improving procedure efficiencies and contributing to improved patient outcomes," said Patrick Romano, Vice President, GI Business Unit Leader, Olympus Corporation of the Americas.
  • A new video highlighting use of the EndoClot PHS and EndoClot SIS has been developed to provide more information: https://www.youtube.com/watch?v=QlCaoiM2Eo0 .

Medicines360 Appoints Lisa David as Chair of the Board of Directors, Strengthening its Commitment to Women’s Health

Retrieved on: 
Wednesday, January 24, 2024
Woman, Health, Gynaecology, Health equity, Administration, PHS, Executive, PPFA, Child, Physician, National Network, Obstetrics, Columbia School of Linguistics, Trustee, Nursing

With decades of experience in the reproductive health community, Ms. David will bring invaluable insights and leadership to Medicines360.

Key Points: 
  • With decades of experience in the reproductive health community, Ms. David will bring invaluable insights and leadership to Medicines360.
  • “I am honored to contribute to Medicines360 in this new role — I know trailblazing work lies ahead,” said Ms. David.
  • “Women consistently face inequitable, daunting barriers to accessing the essential medicines and health innovations they need.
  • Ms. David also previously served on the board of trustees of the Women’s Health Activist Movement Global .

Celltrion presents strategic vision and growth plan at the 42nd Annual J.P. Morgan Healthcare Conference

Retrieved on: 
Thursday, January 11, 2024
Celltrion, Patient, Health, Intelligence, Biosimilar, PHS, Infliximab, Conference, Drug development, FDA, Pharmaceutical industry

Celltrion's Chairman Jung-Jin Seo and CEO Jin-Seok Seo discussed the company's strategic priorities and progress, including the company's vision to move beyond biosimilars through the 2024 launch of ZYMFENTRA™ in the U.S. and expansion into digital healthcare.

Key Points: 
  • Celltrion's Chairman Jung-Jin Seo and CEO Jin-Seok Seo discussed the company's strategic priorities and progress, including the company's vision to move beyond biosimilars through the 2024 launch of ZYMFENTRA™ in the U.S. and expansion into digital healthcare.
  • He also shared insights and trends on the biosimilar industry and how the market landscape is impacting Celltrion's strategy.
  • Jin-Seok Seo said, ''Celltrion has the potential to grow its revenue by at least fivefold in 2030, once our 22-drug portfolio is commercialized.
  • Celltrion remains committed to pursuing its goal in promoting the health and well-being of patients."

Pumped Hydro Storage Opportunity in India, 2023 Market Report Featuring Greenko, JSW, Adani, Andritz, and NTPC - ResearchAndMarkets.com

Retrieved on: 
Wednesday, December 13, 2023
Alternative Energy, Energy, PHS, Research, Polysilazane, Government, Weather, Season, Wind, BESS, Water, Original equipment manufacturer, Electricity, Kilowatt-hour, Pumped-storage hydroelectricity, Renewable energy, Landfill

This research report on Pumped Hydro Storage will enable readers to get a perspective on potential, regulatory framework, planned & upcoming projects in different states, developers, success determinants and risks.

Key Points: 
  • This research report on Pumped Hydro Storage will enable readers to get a perspective on potential, regulatory framework, planned & upcoming projects in different states, developers, success determinants and risks.
  • The Indian Government has also recently revised its figure of pumped storage hydropower potential from 96 GW to 106 GW.
  • The Union Ministry of Power has come out with draft guidelines on pumped hydro storage projects.
  • Pumped Storage Projects account for over 95% of installed global energy storage capacity, well ahead of lithium-ion and other battery types.

India Pumped Hydro Storage Industry Report 2023-2030: Renaissance of Age-Old Self-Sustaining Water Battery Technology to Overshadow Battery Energy Storage

Retrieved on: 
Tuesday, December 12, 2023
PHS, Research, Polysilazane, Government, Weather, Season, Wind, BESS, Water, Original equipment manufacturer, Electricity, Kilowatt-hour, Pumped-storage hydroelectricity, Renewable energy, Landfill

DUBLIN, Dec. 12, 2023 /PRNewswire/ -- The "Pumped Hydro Storage Opportunity in India" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • DUBLIN, Dec. 12, 2023 /PRNewswire/ -- The "Pumped Hydro Storage Opportunity in India" report has been added to ResearchAndMarkets.com's offering.
  • Pumped hydro storage projects (PHPs) is a commonly used technology in which water is pumped from a lower elevation reservoir to a higher elevation using low-cost surplus off-peak electric power to run the pumps.
  • The Union Ministry of Power has come out with draft guidelines on pumped hydro storage projects.
  • Pumped Storage Projects account for over 95% of installed global energy storage capacity, well ahead of lithium-ion and other battery types.

PURE Bioscience Reports Fiscal 2023 Financial Results

Retrieved on: 
Monday, October 30, 2023
Retail, Health, Health Technology, Agriculture, Natural Resources, Food, Beverage, Biotechnology, FDA, Insurance, Sanitation, PHS, SDC, PURE, Social media, Food industry, Water, Sustainability, International Association for Food Protection, Job satisfaction, Corporation, Professional conference organiser, Electricity, International Association, OTCQB, Interface (computing), Carbon footprint, IAFP, Q3, Geographic Locator Codes, University, El Cajon, California, Pure Telecom, Chemistry, Disinfectant, Cryptocurrency, Video game, Management, Q4

PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal year ended July 31, 2023.

Key Points: 
  • PURE Bioscience, Inc. ( OTCQB: PURE ) (“PURE,” the “Company” or “we”), creator of the patented non-toxic silver dihydrogen citrate ( SDC ) antimicrobial, today reported financial results for the fiscal year ended July 31, 2023.
  • Net loss for the fiscal year ended July 31, 2023 was ($4.0 million), compared to ($3.5 million) for the fiscal year ended July 31, 2022.
  • Net loss, excluding share-based compensation, for the fiscal year ended July 31, 2023 was ($3.6 million), compared to ($2.9 million) for the fiscal year ended July 31, 2022.
  • Net cash used in operations for the fiscal year ended July 31, 2023 was ($3.3 million), compared to ($2.5 million) for the fiscal year ended July 31, 2022.